Cacdac Robert, Jamali Arsia, Jamali Raika, Nemovi Khashayar, Vosoughi Kia, Bayraktutar Zeynep
Department of Internal Medicine, Eisenhower Medical Center, Rancho Mirage, CA, USA.
Research Development Center of Sina Hospital, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
SAGE Open Med Case Rep. 2022 Oct 24;10:2050313X221131169. doi: 10.1177/2050313X221131169. eCollection 2022.
While vaccination against COVID-19 has significantly improved the morbidity and mortality of the disease, with the increase in the administration of COVID-19 vaccines, it is more likely to observe their rare side effects in the clinical settings. Herein, we report a case of an 82-year-old man with history of coronary artery disease, prostate cancer in remission, gastroesophageal reflux disease, and hypothyroidism, who presented with acute pancreatitis few hours after receiving the third dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine, without other identified etiology. His symptoms were mild and he was discharged in a stable condition after improvement in his condition with supportive care.
虽然接种新冠病毒疫苗显著改善了该疾病的发病率和死亡率，但随着新冠病毒疫苗接种量的增加，在临床环境中更有可能观察到其罕见的副作用。在此，我们报告一例82岁男性病例，该患者有冠状动脉疾病、处于缓解期的前列腺癌、胃食管反流病和甲状腺功能减退病史，在接种第三剂辉瑞 - 生物科技公司的BNT162b2 mRNA新冠病毒疫苗后数小时出现急性胰腺炎，且未发现其他病因。他的症状较轻，经支持治疗病情改善后稳定出院。
